Biomet managing Zimmer ?

Quote













Anonymous said:
Do tell? Already gone but curious to see how this all plays out. Especially with the deal not even done.
Click to expand...

for the lazy: http://investor.zimmer.com/releaseDetail.cfm?ReleaseID=879305&id=14

-Zimmer: 7. Quality, Legal, HR
*Biomet: 5. Operations, Finance
Mixed: Divisional and sales management.

WARSAW, Ind., Oct. 30, 2014 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH and SIX: ZMH) today announced the future executive leadership team and organizational structure of the combined company following the closing of the Biomet transaction. Zimmer also announced that the combined organization will leverage the strength of both companies' brands and will be named Zimmer Biomet, with the new brand to be rolled out across the combined company following the closing of the merger. The future leadership team is committed to establishing Zimmer Biomet as a global musculoskeletal healthcare leader by building upon the principles and practices that have made both companies so successful.

ZIMMER, INC. LOGO
"These announcements mark important milestones that will help advance the effective integration of our two companies upon closing," said David Dvorak, President and CEO of Zimmer, who, as previously announced, will continue as President and CEO of the combined company. "Zimmer and Biomet each have extraordinary talent across all levels, and we are confident that we have put in place a team and organizational structure to drive the combined company into this new chapter. In addition, becoming Zimmer Biomet brings together two well-respected and recognizable names in the industry that share a commitment to new innovations that enhance patient outcomes and improve quality of life."

The executive leadership team of the new Zimmer Biomet will comprise 12 executives reporting directly to Dvorak, and will be organized around three business units, three geographic regions and six functional areas.

Zimmer Biomet business units and leadership:

*Adam R. Johnson, Group President, with responsibility for the Spine, Microfixation, Bone Healing and Dental businesses. Johnson has served in leadership roles at Biomet for 12 years. Johnson currently leads Biomet's Spine, Microfixation and Bone Healing Division.
-David A. Nolan, Group President, with responsibility for the Sports Medicine, Extremities, Trauma, Biologics and Surgical businesses. Nolan has more than 20 years of experience in commercial leadership roles at Biomet and Zimmer. Nolan currently leads Zimmer's Advanced Solutions portfolio.
*Daniel E. Williamson, Group President, with responsibility for the Knee, Hip and Bone Cement businesses. Williamson has served in senior leadership roles at Biomet for 24 years. Williamson currently leads Biomet's Reconstructive Division.
Zimmer Biomet geographic regions and leadership:

*Stuart G. Kleopfer, President, Americas. The Americas region will be comprised of the United States, Canada and Latin America. Kleopfer has held the U.S. executive leadership position at Biomet for four years and has been with Biomet for 26 years.
-Katarzyna Mazur-Hofsaess, M.D., Ph.D., President, EMEA. The EMEA region will be comprised of Europe, the Middle East and Africa. Mazur-Hofsaess has held an EMEA senior leadership position with Zimmer for four years.
-Sang Yi, President, Asia Pacific. The Asia Pacific region will be comprised of China, Japan, India, Australia, New Zealand, Korea and Southeast Asia. Yi has held an Asia Pacific senior leadership position with Zimmer for two years. Stephen H.L. Ooi, Zimmer President, Asia Pacific, will retire from his current position at the close of the transaction. Ooi will serve in an advisory role following the close.

Zimmer Biomet functional areas and leadership:

*Robin T. Barney, Senior Vice President, Global Operations and Logistics. Barney has held the Global Operations and Logistics executive leadership position at Biomet for seven years.
Audrey M. Beckman, Senior Vice President, Strategic Quality Initiatives. Beckman has served in senior leadership roles at Zimmer for 18 years and has been with the Company for 28 years.
-William P. Fisher, Senior Vice President, Global Human Resources. Fisher has held the Global Human Resources executive leadership position at Zimmer for five years.
*Daniel P. Florin, Senior Vice President, Chief Financial Officer. Florin has served as the Chief Financial Officer at Biomet for seven years. James T. Crines, Zimmer Chief Financial Officer, will retire from his current position at the close of the transaction. Crines will serve in an advisory role following the close.
-Emmanuel O. Nyakako, Senior Vice President, Global Quality, Clinical and Regulatory Affairs. Nyakako has held the Global Quality, Clinical and Regulatory Affairs executive leadership position at Zimmer for two years.
-Chad F. Phipps, Senior Vice President, General Counsel and Secretary. Phipps has held the General Counsel position at Zimmer for seven years.
-Dvorak continued, "Our two companies will be stronger together, and that is proven by the management team we have assembled. With the help of these individuals, and many more across both organizations, we are making great progress in our integration planning and are positioned to immediately begin capturing the benefits of the combination upon closing. I also want to recognize all of our leaders for their continued guidance as we plan for the new Zimmer Biomet and thank those who will be continuing in advisory roles following the closing to help ensure a seamless transition and integration."

Until the closing of the transaction, the respective companies will continue to operate under their current leadership structure and as two separate organizations.

As previously announced on April 24, 2014, Zimmer and Biomet agreed to combine in a transaction valued at approximately $13.35 billion. The combination, which is expected to close in the first quarter of 2015, remains subject to the expiration or termination of the applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, approval from the European Commission and the Japan Fair Trade Commission, as well as other customary closing conditions. It is expected that the combined company's shares will trade on the New York Stock Exchange under Zimmer's current ticker symbol of "ZMH" following the closing.
 









A lot of the higher ranked Zimmer and Biomet folks that were not mentioned, will take their stock options or equity position.....and run! Best in the long run. They names mentioned to be "in charge" are great leaders and will do the new Zimmer/Biomet well. Hopefully this is the first of a lot of good, well thought out decisions. So far, so good. Dvorak is making this happen!
 



Anonymous said:
A lot of the higher ranked Zimmer and Biomet folks that were not mentioned, will take their stock options or equity position.....and run! Best in the long run. They names mentioned to be "in charge" are great leaders and will do the new Zimmer/Biomet well. Hopefully this is the first of a lot of good, well thought out decisions. So far, so good. Dvorak is making this happen!
Click to expand...

I agree. Let's get it on!
 



Anonymous said:
A lot of the higher ranked Zimmer and Biomet folks that were not mentioned, will take their stock options or equity position.....and run! Best in the long run. They names mentioned to be "in charge" are great leaders and will do the new Zimmer/Biomet well. Hopefully this is the first of a lot of good, well thought out decisions. So far, so good. Dvorak is making this happen!
Click to expand...

Things are finally starting to look up around here! Maybe Dvorak realizes that he has one chance to fix all the shit that's happened over the past few years. Get rid of those that created the mess we have. Of course the Biomet leadership is better qualified. Better culture and better talent to choose from. Big must be in heaven right now. I know some of the leaders from Biomet on the list and like it or not they're the best of the best!


Excited about the future...
 















One name I don't see is todd davis. Say what you want he helped us zimmer quite a bit and I heard he did great at biomet. Is is divorak willing to put personal feelings aside to have a winner on his team again
 



Anonymous said:
One name I don't see is todd davis. Say what you want he helped us zimmer quite a bit and I heard he did great at biomet. Is is divorak willing to put personal feelings aside to have a winner on his team again
Click to expand...

Davis is a great guy and does is job exceptionally well. I heard he had a meeting with DD and they've moved past whatever happened before. In my humble opinion if TD is a part of the future in the new company that means DD is serious about this company being different and the best it can be.

If Todd is going to be a part of it I expect he will be named in L2.
 



Anonymous said:
Davis is a great guy and does is job exceptionally well. I heard he had a meeting with DD and they've moved past whatever happened before. In my humble opinion if TD is a part of the future in the new company that means DD is serious about this company being different and the best it can be.

If Todd is going to be a part of it I expect he will be named in L2.
Click to expand...

when is l2 coming?
 



Anonymous said:
when is l2 coming?
Click to expand...

Right about the same time as the layoffs!

It is very interesting that the big jobs so far in recon are going to the Biomet folks. What does it say about Zimmer when employees are excited and encouraged that the new leadership is from the other company? Current Zimmer leadership talks about empowerment and balance of life, but so far it is all still just talk. All they seem to do is fight among themselves and take forever to reach any kind of decision, no matter how obvious. And when they finally do, it is too late for everyone else to adjust and deliver. It is really all about late decisions, micromanagement, and impossible deadlines. The stress level has never been higher, job satisfaction has never been lower. All the uncertainty about the "merger" makes it worse. The only bright spot is the fact that Biomet execs will be running things and that gives a slight hope that a real culture change may be on the way - not just talk.
 



Anonymous said:
Right about the same time as the layoffs!

It is very interesting that the big jobs so far in recon are going to the Biomet folks. What does it say about Zimmer when employees are excited and encouraged that the new leadership is from the other company? Current Zimmer leadership talks about empowerment and balance of life, but so far it is all still just talk. All they seem to do is fight among themselves and take forever to reach any kind of decision, no matter how obvious. And when they finally do, it is too late for everyone else to adjust and deliver. It is really all about late decisions, micromanagement, and impossible deadlines. The stress level has never been higher, job satisfaction has never been lower. All the uncertainty about the "merger" makes it worse. The only bright spot is the fact that Biomet execs will be running things and that gives a slight hope that a real culture change may be on the way - not just talk.
Click to expand...

As highly touted as the Gallup Survey process for employee engagement has been (in theory, not so in practice), it would be interesting to see the results of the survey relative to the current moment, and whether they'd use that for any guidance on leadership decisions to keep people engaged and interested in remaining a part of the company.
 



Anonymous said:
Right about the same time as the layoffs!

It is very interesting that the big jobs so far in recon are going to the Biomet folks. What does it say about Zimmer when employees are excited and encouraged that the new leadership is from the other company? Current Zimmer leadership talks about empowerment and balance of life, but so far it is all still just talk. All they seem to do is fight among themselves and take forever to reach any kind of decision, no matter how obvious. And when they finally do, it is too late for everyone else to adjust and deliver. It is really all about late decisions, micromanagement, and impossible deadlines. The stress level has never been higher, job satisfaction has never been lower. All the uncertainty about the "merger" makes it worse. The only bright spot is the fact that Biomet execs will be running things and that gives a slight hope that a real culture change may be on the way - not just talk.
Click to expand...

Of course we want the Biomet leadership. How can anything improve with our current management? They're the ones that have got us here.

Unfortunately people will be let go. That's because of redundantancies. Be glad Biomet is involved because at least we know it will be done with some thought for the people. It's unfortunate that some will be without a job but it's part of this. Maybe when we see L3 some people will just leave on their own.

I know a lot of people who work at Biomet and they love it there. Let's just hope our guys don't screw up that culture. Let's be real, we've got a bunch of idiots on our side.
 



Top Bottom
Back
Quote